News
ANIP
--
0.00%
--
ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that the Compensation Committee of ANI’s Board of Directors granted a non-qualified inducement stock option to purchase an aggregate of 179,643 shares of ANI’s common stock to Nikhil Lalwani, President
Business Wire · 09/11 00:00
ANI Pharmaceuticals (ANIP) Q2 Earnings Miss Estimates
ANI (ANIP) delivered earnings and revenue surprises of -2.82% and 6.06%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/06 12:35
ANI Pharmaceuticals Reports Second Quarter 2020 Results
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2020.
Business Wire · 08/06 10:50
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio "Tony" Pera to Board of Directors
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq:ANIP) today announced the appointments of Jeanne Thoma, President and Chief Executive Officer of SPI Pharma, Inc. and Antonio ("Tony") Pera, former President of Par Pharmaceutical to the ANI Pharmaceut
Business Wire · 08/06 10:45
New chief at ANI Pharmaceuticals
Effective September 8, ANI Pharmaceuticals (NASDAQ:ANIP) appoints Nikhil Lalwani as President and CEO succeeding Patrick D. Walsh Mr. Walsh to continue as
seekingalpha · 08/03 16:45
Raymond James Maintains Outperform on ANI Pharmaceuticals, Lowers Price Target to $40
Raymond James maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Outperform and lowers the price target from $49 to $40.
Benzinga · 08/03 12:38
ANI Pharmaceuticals Names Nikhil Lalwani As President And Chief Executive Officer
Benzinga · 08/03 10:52
ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that Nikhil Lalwani has been named the Company’s President and Chief Executive Officer, effective September 8, 2020. Mr. Lalwani will also be elected to the Company’s Board of Di
Business Wire · 08/03 10:50
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ: ANIP) today announced that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, before the opening of the U.S. financial markets.
Business Wire · 07/30 10:50
Earnings Preview: ANI Pharmaceuticals (ANIP) Q2 Earnings Expected to Decline
ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/29 16:33
Seeking Alpha Catalyst Watch
News is free at Seeking Alpha. This post is a Premium News Insight. Premium News Insights are a Premium feature. To access this and other Premium News Insi
seekingalpha · 07/18 00:38
ANI Pharmaceuticals shares are trading lower after the company filed for a $350 million mixed securities shelf offering.
Benzinga · 07/10 16:23
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)
Benzinga · 07/10 11:25
Mixed shelf roundup - healthcare
The following medical companies have filed for mixed shelf offerings: Ardelyx (ARDX -4.5%): $250M. Vaxart (VXRT +1.7%): $100M. Alpine Immune Sciences (ALPN
seekingalpha · 07/09 21:34
ANI Pharma S-3 Shows Registration For $350M Mixed Securities Shelf Offering
Benzinga · 07/09 20:27
New Strong Sell Stocks for July 8th
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
Zacks · 07/08 11:38
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets
PR Newswire · 07/06 13:30
ANI Pharmaceuticals Announces Acquisition Of Fluconazole Tablets
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets BAUDETTE, Minn., July 6, 2020 /PRNewswire/ --ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ:ANIP) today announced the acquisition of
Benzinga · 07/06 12:31
Hedge Funds Are Selling ANI Pharmaceuticals Inc (ANIP)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter
Insider Monkey · 07/05 00:54
ANI Pharmaceuticals Announces Launch Of Mexiletine Hydrochloride Capsules
BAUDETTE, Minn., June 30, 2020 /PRNewswire/ --ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current
Benzinga · 06/30 12:36